OptiBiotix Health Plc (OPTI)の価格はいくらですか

OptiBiotix Health Plc (OPTI)の価格は$0.07994122です

OptiBiotix Health Plc (OPTI)の時価総額は何ですか

OptiBiotix Health Plc (OPTI)の時価総額は$82.58Kです

OptiBiotix Health Plc（OPTI）PSR（株価売上高倍率）

OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.

年	P/S比率	変化
2026 (TTM)	5.63	-72.23%
2024	20.26	-45.93%
2023	37.46	46.37%
2022	25.60	40.61%
2021	18.20	-45.19%
2020	33.21	-56.04%
2019	75.55	-49.47%
2018	149.51	-52.86%
2017	317.18	80.98%
2016	175.26	-92.15%
2015	2.23K	0.00%
2014	0.00	0.00%
2013	0.00	-100.00%
2012	3.96	-94.63%
2011	73.72	0.00%
2010	0.00	0.00%
2009	0.00	0.00%
2008	0.00	0.00%
2007	0.00	0.00%

年

P/S比率

変化

2026 (TTM)

5.63

-72.23%

2024

20.26

-45.93%

2023

37.46

46.37%

2022

25.60

40.61%

2021

18.20

-45.19%

2020

33.21

-56.04%

2019

75.55

-49.47%

2018

149.51

-52.86%

2017

317.18

80.98%

2016

175.26

-92.15%

2015

2.23K

0.00%

2014

0.00

0.00%

2013

0.00

-100.00%

2012

3.96

-94.63%

2011

73.72

0.00%

2010

0.00

0.00%

2009

0.00

0.00%

2008

0.00

0.00%

2007

0.00

0.00%

企業	P/S比率	P/S比率の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	10.44	85.66%	US
Moderna, Inc. MRNA.US	26.12	364.37%	US
Argenx SE ARGX.US	12.01	113.43%	NL
CSL Limited CSL.AX	3.76	-33.25%	AU
Lonza Group AG LONN.SW	-	-	CH

企業

P/S比率

P/S比率の差

国